XML 28 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share

14. Net Loss per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):

 

 

Three Months Ended September 30,

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$

(10,470

)

 

$

(60,739

)

 

$

(41,419

)

 

$

(151,482

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding, basic and diluted

 

 

170,169,865

 

 

 

119,495,284

 

 

 

136,874,025

 

 

 

118,163,599

 

Net loss per share attributable to common stockholders, basic and diluted

 

$

(0.06

)

 

$

(0.51

)

 

$

(0.30

)

 

$

(1.28

)

 

The 21,342,442 shares of common stock issuable upon exercise of pre-funded warrants described in Note 10 are included as outstanding common stock in the calculation of net loss per common share.

Shares of unvested restricted common stock are not considered outstanding for accounting purposes until vested and were excluded from the calculations of basic net loss per share attributable to common stockholders for the three and nine months ended September 30, 2025. There were no shares of unvested restricted common stock for the three and nine months ended September 30, 2024.

The Company’s potential dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated, because including them would have had an anti-dilutive effect:

 

 

For the Nine Months
Ended September 30,

 

 

For the Nine Months
Ended September 30,

 

 

 

2025

 

 

2024

 

Stock options to purchase common stock

 

 

21,316,902

 

 

 

21,875,754

 

Restricted stock units

 

 

1,539,000

 

 

 

 

Warrants to purchase common stock

 

 

6,824,712

 

 

 

6,824,712

 

 

 

 

29,680,614

 

 

 

28,700,466